<?xml version="1.0" encoding="UTF-8"?>
<p>Patients were treated according to national guidelines, which generally included chemotherapy with or without radiotherapy (
 <xref rid="pone.0204870.t001" ref-type="table">Table 1</xref>). Since the material included patients diagnosed with primary cHL over a long time period (1980â€“2015), chemotherapy regimens differed (
 <xref rid="pone.0204870.t001" ref-type="table">Table 1</xref>). Relapsed disease was treated with high-dose chemotherapy and autologous stem cell transplantation (ASCT) in young patients with limited comorbidity.
</p>
